Hypertension after experimental cerebral ischemia: Candesartan provides neurovascular protection

Susan C. Fagan, Anna Kozak, William D Hill, David M. Pollock, Lin Xu, Maribeth H Johnson, Adviye Ergul, David C Hess

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: After ischemic stroke, hypertension increases the risk of recurrence, hemorrhage and fatal cerebral edema, but blood pressure (BP) lowering in the acute stroke period is controversial due to fears of infarct extension and worsened outcomes. Objective: To determine whether BP lowering with candesartan, initiated at reperfusion, can reduce neurovascular damage and improve outcome in a model of hypertension after experimental ischemic stroke. Methods: Male Wistar rats (280-305 g) underwent 3 h of middle cerebral artery occlusion (MCAO). At reperfusion, either saline (n = 18) or candesartan 1 mg/kg (n = 18) was administered intravenously. BP was measured by telemetry for 2 days before and 24 h after MCAO. Neurologic function was assessed and sacrifice occurred at 24 h after occlusion. Brain tissue was analyzed for infarct size, hemoglobin content and edema. Results: Mean BP increased from 96 to 124 mmHg immediately upon MCAO and decreased to 114 mmHg after reperfusion, remaining elevated for 24 h (P < 0.001) in the saline group. Candesartan reduced BP back to baseline and BP remained lower than in saline-treated animals until sacrifice (P < 0.001). Infarct size (54 versus 38%, P = 0.01) and hemoglobin content (23.4 versus 10.0 μg/g tissue; P = 0.03) and edema (17.97 versus 11.33%, P < 0.0001) were lower in the candesartan group. In addition, neurologic function at 24 h was improved (P = 0.0036) in the candesartan group. Conclusions: Candesartan administered after reperfusion in acute ischemic stroke reduces neurovascular damage and improves outcome.

Original languageEnglish (US)
Pages (from-to)535-539
Number of pages5
JournalJournal of hypertension
Volume24
Issue number3
DOIs
StatePublished - Mar 2006

Fingerprint

Brain Ischemia
Blood Pressure
Hypertension
Reperfusion
Middle Cerebral Artery Infarction
Stroke
Nervous System
Edema
Hemoglobins
Telemetry
Brain Edema
Fear
candesartan
Wistar Rats
Hemorrhage
Recurrence
Brain

Keywords

  • Candesartan
  • Hypertension
  • Stroke
  • Vascular protection

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Hypertension after experimental cerebral ischemia : Candesartan provides neurovascular protection. / Fagan, Susan C.; Kozak, Anna; Hill, William D; Pollock, David M.; Xu, Lin; Johnson, Maribeth H; Ergul, Adviye; Hess, David C.

In: Journal of hypertension, Vol. 24, No. 3, 03.2006, p. 535-539.

Research output: Contribution to journalArticle

Fagan, Susan C. ; Kozak, Anna ; Hill, William D ; Pollock, David M. ; Xu, Lin ; Johnson, Maribeth H ; Ergul, Adviye ; Hess, David C. / Hypertension after experimental cerebral ischemia : Candesartan provides neurovascular protection. In: Journal of hypertension. 2006 ; Vol. 24, No. 3. pp. 535-539.
@article{187e36bae2db4f45b8dbc7b97a11a0fd,
title = "Hypertension after experimental cerebral ischemia: Candesartan provides neurovascular protection",
abstract = "Background: After ischemic stroke, hypertension increases the risk of recurrence, hemorrhage and fatal cerebral edema, but blood pressure (BP) lowering in the acute stroke period is controversial due to fears of infarct extension and worsened outcomes. Objective: To determine whether BP lowering with candesartan, initiated at reperfusion, can reduce neurovascular damage and improve outcome in a model of hypertension after experimental ischemic stroke. Methods: Male Wistar rats (280-305 g) underwent 3 h of middle cerebral artery occlusion (MCAO). At reperfusion, either saline (n = 18) or candesartan 1 mg/kg (n = 18) was administered intravenously. BP was measured by telemetry for 2 days before and 24 h after MCAO. Neurologic function was assessed and sacrifice occurred at 24 h after occlusion. Brain tissue was analyzed for infarct size, hemoglobin content and edema. Results: Mean BP increased from 96 to 124 mmHg immediately upon MCAO and decreased to 114 mmHg after reperfusion, remaining elevated for 24 h (P < 0.001) in the saline group. Candesartan reduced BP back to baseline and BP remained lower than in saline-treated animals until sacrifice (P < 0.001). Infarct size (54 versus 38{\%}, P = 0.01) and hemoglobin content (23.4 versus 10.0 μg/g tissue; P = 0.03) and edema (17.97 versus 11.33{\%}, P < 0.0001) were lower in the candesartan group. In addition, neurologic function at 24 h was improved (P = 0.0036) in the candesartan group. Conclusions: Candesartan administered after reperfusion in acute ischemic stroke reduces neurovascular damage and improves outcome.",
keywords = "Candesartan, Hypertension, Stroke, Vascular protection",
author = "Fagan, {Susan C.} and Anna Kozak and Hill, {William D} and Pollock, {David M.} and Lin Xu and Johnson, {Maribeth H} and Adviye Ergul and Hess, {David C}",
year = "2006",
month = "3",
doi = "10.1097/01.hjh.0000209990.41304.43",
language = "English (US)",
volume = "24",
pages = "535--539",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Hypertension after experimental cerebral ischemia

T2 - Candesartan provides neurovascular protection

AU - Fagan, Susan C.

AU - Kozak, Anna

AU - Hill, William D

AU - Pollock, David M.

AU - Xu, Lin

AU - Johnson, Maribeth H

AU - Ergul, Adviye

AU - Hess, David C

PY - 2006/3

Y1 - 2006/3

N2 - Background: After ischemic stroke, hypertension increases the risk of recurrence, hemorrhage and fatal cerebral edema, but blood pressure (BP) lowering in the acute stroke period is controversial due to fears of infarct extension and worsened outcomes. Objective: To determine whether BP lowering with candesartan, initiated at reperfusion, can reduce neurovascular damage and improve outcome in a model of hypertension after experimental ischemic stroke. Methods: Male Wistar rats (280-305 g) underwent 3 h of middle cerebral artery occlusion (MCAO). At reperfusion, either saline (n = 18) or candesartan 1 mg/kg (n = 18) was administered intravenously. BP was measured by telemetry for 2 days before and 24 h after MCAO. Neurologic function was assessed and sacrifice occurred at 24 h after occlusion. Brain tissue was analyzed for infarct size, hemoglobin content and edema. Results: Mean BP increased from 96 to 124 mmHg immediately upon MCAO and decreased to 114 mmHg after reperfusion, remaining elevated for 24 h (P < 0.001) in the saline group. Candesartan reduced BP back to baseline and BP remained lower than in saline-treated animals until sacrifice (P < 0.001). Infarct size (54 versus 38%, P = 0.01) and hemoglobin content (23.4 versus 10.0 μg/g tissue; P = 0.03) and edema (17.97 versus 11.33%, P < 0.0001) were lower in the candesartan group. In addition, neurologic function at 24 h was improved (P = 0.0036) in the candesartan group. Conclusions: Candesartan administered after reperfusion in acute ischemic stroke reduces neurovascular damage and improves outcome.

AB - Background: After ischemic stroke, hypertension increases the risk of recurrence, hemorrhage and fatal cerebral edema, but blood pressure (BP) lowering in the acute stroke period is controversial due to fears of infarct extension and worsened outcomes. Objective: To determine whether BP lowering with candesartan, initiated at reperfusion, can reduce neurovascular damage and improve outcome in a model of hypertension after experimental ischemic stroke. Methods: Male Wistar rats (280-305 g) underwent 3 h of middle cerebral artery occlusion (MCAO). At reperfusion, either saline (n = 18) or candesartan 1 mg/kg (n = 18) was administered intravenously. BP was measured by telemetry for 2 days before and 24 h after MCAO. Neurologic function was assessed and sacrifice occurred at 24 h after occlusion. Brain tissue was analyzed for infarct size, hemoglobin content and edema. Results: Mean BP increased from 96 to 124 mmHg immediately upon MCAO and decreased to 114 mmHg after reperfusion, remaining elevated for 24 h (P < 0.001) in the saline group. Candesartan reduced BP back to baseline and BP remained lower than in saline-treated animals until sacrifice (P < 0.001). Infarct size (54 versus 38%, P = 0.01) and hemoglobin content (23.4 versus 10.0 μg/g tissue; P = 0.03) and edema (17.97 versus 11.33%, P < 0.0001) were lower in the candesartan group. In addition, neurologic function at 24 h was improved (P = 0.0036) in the candesartan group. Conclusions: Candesartan administered after reperfusion in acute ischemic stroke reduces neurovascular damage and improves outcome.

KW - Candesartan

KW - Hypertension

KW - Stroke

KW - Vascular protection

UR - http://www.scopus.com/inward/record.url?scp=32944470069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32944470069&partnerID=8YFLogxK

U2 - 10.1097/01.hjh.0000209990.41304.43

DO - 10.1097/01.hjh.0000209990.41304.43

M3 - Article

C2 - 16467657

AN - SCOPUS:32944470069

VL - 24

SP - 535

EP - 539

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 3

ER -